[1]
2023. Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems. ADMET and DMPK. 12, 1 (Nov. 2023), 167–176. DOI:https://doi.org/10.5599/admet.2022.